TECHNOLOGY LICENSING OPPORTUNITY: Heat Pipe Reactor Wick and Fill Platform RFP
Description: High-temperature heat pipe reactors by improving the way critical wick structures are manufactured and how heat pipe arrays are filled, sealed, and checked for quality.
Original attachments and procurement documents tied to this bid.
Federal RFP files are for Starbridge customers only.
You can request RFP files from all other buyer types for free on this site.
See your top accountsScan your site in seconds. Starbridge identifies your ICP and surfaces emerging opportunities from board meetings, job changes, new grants, contract expirations, RFPs, and more.
The heat pipe reactor fire mitigation and suppression system from laboratory, transforms the heat pipes inside an alkali metal-cooled nuclear reactor from passive thermal conduits into active, sensor-driven fire defense components, giving designers of advanced small and microreactors a layered, automated safeguard against one of the most challenging hazards in their systems. By combining an inert gas buffer, a phase change material jacket, automated suppressant injection at multiple points and optional neutron-absorber dispersion into the reactor core, the system delivers redundant protection that responds within milliseconds of detecting fire-like conditions. This system enables advanced reactor developers to meet stringent safety expectations for remote, unattended and space-constrained deployments without redesigning the core architecture around bulky external suppression equipment.
A novel platform for improving the safety and effectiveness of therapeutic gas-based treatments by enabling controlled, localized delivery at the site of disease. By addressing longstanding challenges associated with systemic exposure and dosing precision, the platform enhances the clinical viability of gas therapies across high-value markets such as oncology, cardiovascular care, and regenerative medicine. In addition, the inclusion of a complementary predictive modeling capability supports treatment optimization and development efficiency, reducing technical risk and accelerating translation. Together, these capabilities position the technology as a differentiated and scalable solution that can unlock new commercial opportunities in areas where gas-based therapeutics have shown promise but faced delivery limitations.
The bacterial lipid nanodiscs platform developed by llaboratory provides a new way to study entire bacterial membranes in a controlled, nanoscale format derived directly from native lipid extracts. Researchers gain access to membrane components that typically remain difficult to isolate, stabilize or analyze, enabling more accurate evaluation of immunogenic lipids and membrane associated targets. The platform offers a safer alternative to handling live high risk pathogens while preserving the biological context that drives meaningful insights for vaccine design and antimicrobial discovery such as therapeutic antibodies to conserved lipids on bacterial membranes.
NanoFiber Engineered Therapeutics Platform (NanoFET) from Laboratory offers pharmaceutical and biodefense organizations a modular, adaptable scaffold for building next-generation immunotherapies. By merging self-assembling peptide nanofibers with interchangeable nanobody and peptide components, the platform enables rapid development of targeted treatments that bridge disease agents directly to the patient’s own immune cells.
